bupropion hydrochloride xl

Generic: bupropion hydrochloride

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride xl
Generic Name bupropion hydrochloride
Labeler a-s medication solutions
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-7113
Product ID 50090-7113_85ec5376-b7ef-4a0b-aa86-6918c483c520
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210015
Listing Expiration 2026-12-31
Marketing Start 2023-04-30

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500907113
Hyphenated Format 50090-7113

Supplemental Identifiers

RxCUI
993541
UNII
ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride xl (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA210015 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-0)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-1)
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-2)
source: ndc

Packages (3)

50090-7113-0 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-0) 50090-7113-1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-1) 50090-7113-2 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-2)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

Bupropion Hydrochloride XL ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "85ec5376-b7ef-4a0b-aa86-6918c483c520", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["6537007e-92c2-43ad-8387-5194cd2aff4c"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-0)", "package_ndc": "50090-7113-0", "marketing_start_date": "20240311"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-1)", "package_ndc": "50090-7113-1", "marketing_start_date": "20240311"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-2)", "package_ndc": "50090-7113-2", "marketing_start_date": "20240311"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "50090-7113_85ec5376-b7ef-4a0b-aa86-6918c483c520", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-7113", "generic_name": "bupropion hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210015", "marketing_category": "ANDA", "marketing_start_date": "20230430", "listing_expiration_date": "20261231"}